fluorodeoxyglucose f18 has been researched along with Carcinoma, Medullary in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (9.68) | 18.2507 |
| 2000's | 34 (54.84) | 29.6817 |
| 2010's | 21 (33.87) | 24.3611 |
| 2020's | 1 (1.61) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W; Hou, G; Jiang, Y; Li, F; Wang, J | 1 |
| Giammarile, F; Maffione, AM; Rubello, D | 1 |
| Ansquer, C; Barbet, J; Borson-Chazot, F; Bournaud, C; Campion, L; Chatal, JF; Drui, D; Frampas, E; Goldenberg, DM; Kraeber-Bodéré, F; Mathieu, C; Mirallié, E; Robin, P; Rousseau, C; Salaun, PY; Taieb, D; Vuillez, JP | 1 |
| Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR | 1 |
| Chang, HT; Chiu, YL; Hu, C; Liu, RS; Peng, NJ | 1 |
| Ciarallo, A; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
| Inoue, T; Ishikawa, T; Kaneta, T; Narui, K; Noritake, M; Sakamaki, K; Sugae, S | 1 |
| Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
| Bergman, J; Kauhanen, S; Korsoff, P; Minn, H; Nuutila, P; Ovaska, J; Salmela, P; Saltevo, J; Sane, T; Seppänen, M; Välimäki, M | 1 |
| Mehta, P; Roman, S; Sosa, JA | 1 |
| Bomanji, JB; Caplin, M; Conry, BG; Kayani, I; Mahmood, S; Papathanasiou, ND; Prakash, V | 1 |
| Bihan, H; Cohen, R; des Guetz, G; Martin, A; Wind, P | 1 |
| Björo, T; Bogsrud, TV; Hay, ID; Karantanis, D; Kasperbauer, JL; Lowe, VJ; Mullan, BP; Nathan, MA; Reading, CC; Wiseman, GA | 1 |
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A | 1 |
| Basu, S; Shet, T | 1 |
| Bauman, JE; Capell, PT; Carr, LL; Eaton, KD; Goulart, BH; Kell, EM; Mankoff, DA; Martins, RG | 1 |
| Choi, JY; Chung, JH; Jang, HW; Kim, HK; Kim, SW; Lee, JI; Shin, HW; Shin, JH | 1 |
| Gong, G; Hong, SJ; Hwang, DW; Lee, AL; Lee, JH; Lee, SR; Lee, YM; Park, KM; Sung, TY; Yoon, JH | 1 |
| Erbay, G; Ibis, E; Kucuk, ON; Ozkan, E; Soydal, C | 1 |
| Choong, KW; Eng, JA; Jackson, TA; Knapp, PE; McAneny, D; Subramaniam, RM | 1 |
| Chondrogiannis, S; Evangelista, L; Gross, MD; Laird, AM; Marzola, MC; Moubayed, A; Rubello, D; Wong, KK | 1 |
| Marzola, MC; Rubello, D | 1 |
| Bao, L; Cheng, X; Li, D; Li, Y; Wang, J; Xu, Z | 1 |
| Giordano, A; Rufini, V; Treglia, G; Villani, MF | 1 |
| Bal, C; Kumar, R; Lata, S; Malhotra, A; Naswa, N; Sharma, P; Suman Kc, S | 1 |
| Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
| Buck, A; Dankerl, A; Glatting, G; Kalker, T; Kotzerke, J; Kühn, T; Mattfeldt, T; Reske, S; Schirrmeister, H; Shen, C | 1 |
| Bourguet, P | 1 |
| Bui, CD; Carlos, RC; Ching, AS; Mukherji, SK; Shreve, PD | 1 |
| Boér, A; Esik, O; Godény, M; Herzog, H; Kásler, M; Klein, I; Péter, I; Szakáll, S; Trón, L; Vincze, B | 1 |
| Battmann, A; Bauhofer, A; Béhé, M; Behr, TM; Beuter, D; Gotthardt, M; Gratz, S; Höffken, H; Klose, KJ; Pollum, H; Schurrat, T | 1 |
| Agarwala, SS; Andrade, RS; Avril, N; Flickinger, J; Heron, DE; Johnson, J; Kalnicki, S; Wu, A | 1 |
| Endo, K; Higuchi, T; Khan, N; Oriuchi, N | 1 |
| Battmann, A; Bauhofer, A; Béhé, MP; Behr, TM; Beuter, D; Gotthardt, M; Oyen, WJ; Pollum, H; Schipper, M; Schurrat, T | 1 |
| Ambrosini, V; Banti, E; Carpi, A; Fanti, S; Farsad, M; Franchi, R; Muzzio, P; Nanni, C; Rampin, L; Rubello, D | 1 |
| Devaux, JY; Duron, F; Grahek, D; Gutman, F; Kerrou, K; Maurel, G; Montravers, F; Périé, S; Saint Guily, JL; Talbot, JN; Younsi, N; Zanotti, P; Zanotti-Fregonara, P | 1 |
| Doddamane, I; Gönen, M; Larson, SM; Ong, SC; Patel, SG; Schöder, H; Shah, JP; Shaha, AR; Tabangay-Lim, IM; Tuttle, RM | 1 |
| Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J | 1 |
| Delorme, S; Fabel, M; Frank-Raue, K; Haberkorn, U; Raue, F | 1 |
| Cunha, ML; Daniel, MM; Funari, MB; Thom, AF; Wagner, J; Yamaga, LY | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
| Aide, N; Bardet, S | 1 |
| Ansquer, C; Barbet, J; Bardet, S; Borson-Chazot, F; Bournaud, C; Campion, L; Chatal, JF; Goldenberg, DM; Kraeber-Bodéré, F; Mirallié, E; Murat, A; Oudoux, A; Rousseau, C; Salaun, PY; Vuillez, JP | 1 |
| Hall, NC; Kloos, RT | 1 |
| Al-Nahhas, A; Banti, E; Fanti, S; Ferdeghini, M; Gross, MD; Nanni, C; Rampin, L; Rubello, D | 1 |
| de Heide, LJ; Jager, PL; Links, TP; Noordzij, MJ; Wolfenbuttel, BH | 1 |
| Ehrlich, L; Kahn, HJ; Mackenzie, R; Nofech-Mozes, S; Raphael, SJ | 1 |
| Calcagni, ML; Leccisotti, L; Perotti, G; Rubello, D; Rufini, V; Treglia, G | 1 |
| Halac, M; Karyagar, S; Karyagar, SS; Mulazimoglu, M; Ozpacaci, T | 1 |
| Einert, A; Laubenberger, JJ; Moser, E; Nitzsche, EU; Simon, GH | 1 |
| Ferlin, G; Gasparoni, P; Rubello, D | 1 |
| Dehdashti, F; Moley, JF; Musholt, PB; Musholt, TJ | 1 |
| James, C; MacGillivray, DC; Starks, M; White, J | 1 |
| Kusuoka, H; Nishimura, T; Shiba, E; Tatsumi, M; Yutani, K | 1 |
| Bacqai, F; Conti, PS; Durski, JM; Grafton, ST; Singer, PA | 1 |
| Bockisch, A; Brandt-Mainz, K; Görges, R; Müller, SP; Saller, B | 1 |
| Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Moser, E; Nitzsche, E | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Füzy, M; Kásler, M; Lengyel, Z; Perner, F; Repa, I; Szakáll, S; Szavcsur, P; Szentirmay, Z; Trón, L | 1 |
| Bohuslavizki, KH; Brandt-Mainz, K; Bredow, J; Diehl, M; Dietlein, M; Grünwald, F; Körber, C; Lange, H; Matheja, P; Risse, JH | 1 |
| Agoston, P; Bajzik, G; Dabasi, G; Esik, O; Repa, I; Sinkovics, I; Szakáll, S; Trón, L | 1 |
| Bouillon, R; De Potter, T; Delaere, P; Drijkoningen, M; Maes, A; Mortelmans, L; Van Damme, B; Van den Bruel, A | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Miklovicz, T; Repa, I; Sinkovics, I; Szakáll, S | 1 |
13 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Medullary
| Article | Year |
|---|---|
Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Medullary thyroid cancer: early detection and novel treatments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review.
Topics: Aged; Biopsy, Fine-Needle; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2009 |
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Mas; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis.
Topics: Carcinoma, Medullary; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2012 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the thyroid].
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 2003 |
Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas.
Topics: Carcinoma; Carcinoma, Medullary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2005 |
Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.
Topics: Carcinoma, Medullary; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2006 |
[PET in thyroid cancers].
Topics: Adenocarcinoma; Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2006 |
PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
Topics: Carcinoma, Medullary; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Whole Body Imaging | 2007 |
Role of PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2008 |
The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism.
Topics: Carcinoma; Carcinoma, Medullary; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperparathyroidism; Iodine Radioisotopes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Parathyroid Hormone; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1999 |
11 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Medullary
| Article | Year |
|---|---|
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Cell Differentiation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Pyrroles; Sunitinib; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2010 |
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Topics: Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed | 2002 |
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature.
Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Germ-Line Mutation; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Mas; Pyrimidines; Survival Analysis; Thyroid Neoplasms | 2007 |
Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Carcinoembryonic Antigen; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Prospective Studies; Radioimmunodetection; Radioimmunotherapy; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2007 |
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography.
Topics: Carcinoma, Medullary; Carcinoma, Papillary, Follicular; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer.
Topics: Adult; Calcitonin; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Radiography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma.
Topics: Adult; Aged; Angiography; Calcitonin; Carcinoma, Medullary; Diagnosis, Differential; Diarrhea; Female; Fluorodeoxyglucose F18; Flushing; Humans; Liver; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
38 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Medullary
| Article | Year |
|---|---|
Renal Medullary Carcinoma on Dual-Time Point FDG PET/CT Imaging.
Topics: Adult; Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Time Factors | 2020 |
SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2017 |
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult | 2016 |
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids; Trastuzumab; Treatment Outcome; Whole Body Imaging | 2017 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Radionuclide Imaging; Recurrence; Thyroid Neoplasms | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy | 2010 |
Unilateral solitary breast metastasis from medullary carcinoma of thyroid detected by FDG-PET.
Topics: Adult; Breast Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroid Neoplasms; Whole Body Imaging | 2010 |
Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT.
Topics: Adult; Aged; Calcitonin; Carbon Radioisotopes; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2010 |
Hepatocellular carcinoma eats medullary thyroid carcinoma, a case of tumor-in-tumor metastasis.
Topics: Carcinoma, Hepatocellular; Carcinoma, Medullary; Fluorodeoxyglucose F18; Histocytochemistry; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Ultrasonography | 2011 |
Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Topics: Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
F-18 FDG PET/CT imaging of endogenous Cushing syndrome.
Topics: Carcinoma, Medullary; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
¹⁸F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Salivary Gland Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
FDG PET imaging in hereditary thyroid cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neoplasm Staging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.
Topics: Adult; Biomarkers, Tumor; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Proteins; Radionuclide Imaging; Radiopharmaceuticals; Receptor, Cholecystokinin B; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2006 |
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
[Diagnostic value of positron emission tomography/computed tomography with fluorine-18 fluordeoxyglucose in patients with differentiated thyroid gland carcinoma, high thyroglobulin serum levels and negative iodine whole body scan].
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
Would patient selection based on both calcitonin blood level and doubling time improve 18F-FDG PET sensitivity in restaging of medullary thyroid cancer?
Topics: Calcitonin; Carcinoma, Medullary; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Topics: Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
[Four patients with incidentalomas of the thyroid discovered on 18-fluoro-deoxyglucose positron-emission tomography (FDG-PET)].
Topics: Adenoma; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2007 |
Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy.
Topics: Bronchitis; Carcinoma, Medullary; Chronic Disease; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
PET imaging of recurrent medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1996 |
Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Blotting, Western; Carcinoma, Medullary; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monosaccharide Transport Proteins; Muscle Proteins; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms | 1997 |
Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
Topics: Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
Topics: Adenoma; Aged; Carcinoma, Medullary; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |